TSER Polymorphism is Not Associated with Risk of Pediatric Acute Lymphoblastic Leukemia: A Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2017 Feb 17

PMID 28207544

Authors

Zhaohua Qiao

Dan Lou

Li Ruan

Affiliations

Soon will be listed here.

Abstract

Background: Accumulating studies have explored the effect of thymidylate synthase enhancer region (TSER) variation on risk of pediatric acute lymphoblastic leukemia (ALL) with controversial results. Therefore, this quantitative meta-analysis was performed to assess synthetically the association of TSER variation with susceptibility to develop pediatric ALL.

Methods: The PubMed, ScienceDirect, Google Scholar, Wanfang Database, and China National Knowledge Infrastructure were systematically retrieved to obtain the published case-control studies about the relationship between TSER variation and pediatric ALL risk. The quality assessment of the included studies was preformed and relevant information was collected. Odds ratios (ORs) and 95% confidence intervals (CIs) were applied to evaluate the strength of association.

Results: This meta-analysis finally included 2681 children with ALL and 3854 matched controls from 11 investigations. The quantitative synthesis results found no significant association between TSER variation and susceptibility to pediatric ALL in overall comparisons under 5 genetic models (2R/3R vs 3R/3R: OR = 0.95, 95% CI = 0.84-1.07, P = 0.41; 2R/2R vs 3R/3R: OR = 0.99, 95% CI = 0.84-1.16, P = 0.90; 2R2R vs 3R/3R+2R/3R: OR = 1.05, 95% CI = 0.92-1.21, P = 0.45; 2R/3R+2R/2R vs 3R/3R: OR = 0.97, 95% CI = 0.87-1.09, P = 0.63; 2R vs 3R: OR = 1.03, 95% CI = 0.92-1.15, P = 0.61). Similarly, there was no significant association existed in the stratification analyses according to ethnicity, control source, and quality score.

Conclusion: This meta-analysis shows that TSER variation is not related to the development risk of pediatric ALL.

References

Mandola M, Stoehlmacher J, Zhang W, Groshen S, Yu M, Iqbal S . A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics. 2004; 14(5):319-27. DOI: 10.1097/00008571-200405000-00007. View

Lin X, Liu J, Maley F, Chu E . Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase. Nucleic Acids Res. 2003; 31(16):4882-7. PMC: 169953. DOI: 10.1093/nar/gkg678. View

Luo W, Li B, Lin F, Yan B, Du Y, Mo X . Joint effects of folate intake and one-carbon-metabolizing genetic polymorphisms on breast cancer risk: a case-control study in China. Sci Rep. 2016; 6:29555. PMC: 4941723. DOI: 10.1038/srep29555. View

Chen J, Hunter D, Stampfer M, Kyte C, Chan W, Wetmur J . Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2003; 12(10):958-62. View

Weng Y, Zhang J, Tang X, Xie X, Chen G . Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis. Leuk Lymphoma. 2011; 53(7):1345-51. DOI: 10.3109/10428194.2011.649477. View

Sharp L, Little J . Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004; 159(5):423-43. DOI: 10.1093/aje/kwh066. View

Inaba H, Greaves M, Mullighan C . Acute lymphoblastic leukaemia. Lancet. 2013; 381(9881):1943-55. PMC: 3816716. DOI: 10.1016/S0140-6736(12)62187-4. View

Silva R, Fontes A, Silva K, SantAna T, Ramos F, Marques-Salles T . Polymorphisms involved in folate metabolism pathways and the risk of the development of childhood acute leukemia. Genet Test Mol Biomarkers. 2013; 17(2):147-52. DOI: 10.1089/gtmb.2012.0174. View

Kawakami K, Watanabe G . Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res. 2003; 63(18):6004-7. View

10.

Kandi V, Vadakedath S . Effect of DNA Methylation in Various Diseases and the Probable Protective Role of Nutrition: A Mini-Review. Cureus. 2015; 7(8):e309. PMC: 4582005. DOI: 10.7759/cureus.309. View

11.

de Bock C, Garg M, Scott N, Sakoff J, Scorgie F, Ackland S . Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo. Pharmacogenomics J. 2010; 11(4):307-14. DOI: 10.1038/tpj.2010.43. View

12.

Zhou J, Shi R, Yu H, Zeng Y, Zheng W, Ma W . Association between polymorphic sites in thymidylate synthase gene and risk of non-Hodgkin lymphoma: a systematic review and pooled analysis. Leuk Lymphoma. 2012; 53(10):1953-60. DOI: 10.3109/10428194.2012.673226. View

13.

Wang J, Wang B, Bi J, Di J . The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010; 128(1):203-9. DOI: 10.1007/s10549-010-1314-0. View

14.

Nakao H, Wakai K, Ishii N, Kobayashi Y, Ito K, Yoneda M . Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. BMC Gastroenterol. 2016; 16(1):83. PMC: 4966808. DOI: 10.1186/s12876-016-0503-7. View

15.

Mandola M, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu M, Lenz H . A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res. 2003; 63(11):2898-904. View

16.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

17.

Yeoh A, Lu Y, Chan J, Chan Y, Ariffin H, Kham S . Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res. 2009; 34(3):276-83. DOI: 10.1016/j.leukres.2009.07.003. View

18.

Duthie S . Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis. 2010; 34(1):101-9. DOI: 10.1007/s10545-010-9128-0. View

19.

Ames B . DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001; 475(1-2):7-20. DOI: 10.1016/s0027-5107(01)00070-7. View

20.

Lightfoot T, Johnston W, Painter D, Simpson J, Roman E, Skibola C . Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood. 2010; 115(19):3923-9. PMC: 2869556. DOI: 10.1182/blood-2009-10-249722. View